Optimization of Head Cluster Selection in WSN by Human-Based Optimization Techniques

Wireless sensor networks (WSNs) are characterized by their ability to monitor physical or chemical phenomena in a static or dynamic location by collecting data, and transmit it in a collaborative manner to one or more processing centers wirelessly using a routing protocol. Energy dissipation is one of the most challenging issues due to the limited power supply at the sensor node. All routing protocols are large consumers of energy, as they represent the main source of energy cost through data exchange operation. Cluster-based hierarchical routing algorithms are known for their good performance in energy conservation during active data exchange in WSNs. The most common of this type of protocol is the Low-Energy Adaptive Clustering Hierarchy (LEACH), which suffers from the problem of the pseudo-random selection of cluster head resulting in large power dissipation. This critical issue can be addressed by using an optimization algorithm to improve the LEACH cluster heads selection process, thus increasing the network lifespan. This paper proposes the LEACH-CHIO, a centralized cluster-based energy-aware protocol based on the Coronavirus Herd Immunity Optimizer (CHIO) algorithm. CHIO is a newly emerging human-based optimization algorithm that is expected to achieve significant improvement in the LEACH cluster heads selection process. LEACH-CHIO is implemented and its performance is verified by simulating different wireless sensor network scenarios, which consist of a variable number of nodes ranging from 20 to 100. To evaluate the algorithm performances, three evaluation indicators have been examined, namely, power consumption, number of live nodes, and number of incoming packets. The simulation results demonstrated the superiority of the proposed protocol over basic LEACH protocol for the three indicators. © 2022 Tech Science Press. All rights reserved.

Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.

Researchers have found many similarities between the 2003 severe acute respiratory syndrome (SARS) virus and SARS-CoV-19 through existing data that reveal the SARS's cause. Artificial intelligence (AI) learning models can be created to predict drug structures that can be used to treat COVID-19. Despite the effectively demonstrated repurposed drugs, more repurposed drugs should be recognized. Furthermore, technological advancements have been helpful in the battle against COVID-19. Machine intelligence technology can support this procedure by rapidly determining adequate and effective drugs against COVID-19 and by overcoming any barrier between a large number of repurposed drugs, laboratory/clinical testing, and final drug authorization. This paper reviews the proposed vaccines and medicines for SARS-CoV-2 and the current application of AI in drug repurposing for COVID-19 treatment.

Deep learning applications to combat the dissemination of COVID-19 disease: a review.

Recent Coronavirus (COVID-19) is one of the respiratory diseases, and it is known as fast infectious ability. This dissemination can be decelerated by diagnosing and quarantining patients with COVID-19 at early stages, thereby saving numerous lives. Reverse transcription-polymerase chain reaction (RT-PCR) is known as one of the primary diagnostic tools. However, RT-PCR tests are costly and time-consuming; it also requires specific materials, equipment, and instruments. Moreover, most countries are suffering from a lack of testing kits because of limitations on budget and techniques. Thus, this standard method is not suitable to meet the requirements of fast detection and tracking during the COVID-19 pandemic, which motived to employ deep learning (DL)/convolutional neural networks (CNNs) technology with X-ray and CT scans for efficient analysis and diagnostic. This study provides insight about the literature that discussed the deep learning technology and its various techniques that are recently developed to combat the dissemination of COVID-19 disease.